Biodesix annual return on equity
2021
2022
2023
2024
2025
Biodesix Return on Equity (ROE) Growth & History (BDSX)
Biodesix's return on equity was −383.09% for fiscal 2025.
View full Biodesix company overviewBiodesix annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −383.09% | −45.79 pp |
| 2024 | 2024-12-31 | −337.30% | +76.79 pp |
| 2023 | 2023-12-31 | −414.09% | −89.55 pp |
| 2022 | 2022-12-31 | −324.53% | −182.78 pp |
| 2021 | 2021-12-31 | −141.75% | — |
Biodesix quarterly return on equity
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q4.23
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −79.59% | +108.44 pp |
| Q1 2026 | 2026-03-31 | −233.78% | −164.26 pp |
| Q2 2025 | 2025-06-30 | −188.03% | −117.75 pp |
| Q1 2025 | 2025-03-31 | −69.52% | — |
| Q4 2024 | 2024-12-31 | −33.86% | +549.35 pp |
| Q3 2024 | 2024-09-30 | −32.00% | — |
| Q2 2024 | 2024-06-30 | −70.28% | — |
| Q4 2023 | 2023-12-31 | −583.22% | −353.45 pp |
| Q1 2023 | 2023-03-31 | −148.69% | −35.37 pp |
| Q4 2022 | 2022-12-31 | −229.77% | −155.48 pp |
| Q3 2022 | 2022-09-30 | −574.62% | −519.54 pp |
| Q2 2022 | 2022-06-30 | −204.81% | −168.16 pp |
| Q1 2022 | 2022-03-31 | −113.32% | −95.38 pp |
| Q4 2021 | 2021-12-31 | −74.28% | — |
| Q3 2021 | 2021-09-30 | −55.08% | — |
| Q2 2021 | 2021-06-30 | −36.66% | — |
| Q1 2021 | 2021-03-31 | −17.94% | — |
Biodesix return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, Biodesix's return on equity decreased from −141.75% to −383.09%, a change of −241.33 percentage points. The latest reported quarter, Q2 2026, shows −79.59%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biodesix source filings ↗